← Open Payments lookup

VIVIAN YOUNG: Open Payments

NPI 1699312926 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$660 in 22 payments from 7 companies in 2025. Trend: 2023 $585 · 2024 $407 · 2025 $660

Food & beverage: $660
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$191
Alkermes, Inc.3$153
Otsuka America Pharmaceutical, Inc.6$115
E.R. Squibb & Sons, L.L.C.4$99
ABBVIE INC.3$57
Vanda Pharmaceuticals Inc.1$22
Neurocrine BioSciences, Inc.1$22

Products named: CAPLYTA, LYBALVI, COBENFY, ABILIFY ASIMTUFII, VRAYLAR, REXULTI, ARISTADA, ABILIFY MAINTENA.

Industry payments across TX — which companies pay providers there.